Physician

Hayman Rambaran, MD

According to 2025 Medicare claims, Hayman Rambaran, MD (NPI: 1639295470) practices addiction medicine in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Passaic, NJ. This provider's primary affiliated billing organization is BERGEN COUNTY IMPROVEMENT AUTHORITY (NPI: 1891836441; TIN: 223240487) and primary practice location at 07652-0442. Rambaran is affiliated with the ilumed, LLC (ACO ID: D0005), participating under the REACH model.

Rambaran's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 33 traditional Medicare patients, billed 39 HCPCS/CPT codes, and received $5,466 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 451 prescription claims across 52 beneficiaries totaling $59,560 in drug costs, led by Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl). Open Payments data shows 18 records totaling $731. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $7,253 and ending at $5,466. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $20,839 to $59,560. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.6K$7.3K2015 Medicare payment: $7,253 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $7,001 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,685 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,467 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,939 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,319 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $5,440 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $6,411 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,125 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,466 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154359$7,253
20164193$7,001
20171819$2,685
20182529$3,467
20192428$2,939
20201414$2,319
20213436$5,440
20223841$6,411
20232730$4,125
20243339$5,466

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$30K$60K2015 Drug cost: $20,839 (USD; Tot_Drug_Cst)2016 Drug cost: $17,472 (USD; Tot_Drug_Cst)2017 Drug cost: $7,929 (USD; Tot_Drug_Cst)2018 Drug cost: $14,181 (USD; Tot_Drug_Cst)2019 Drug cost: $24,944 (USD; Tot_Drug_Cst)2020 Drug cost: $21,432 (USD; Tot_Drug_Cst)2021 Drug cost: $27,555 (USD; Tot_Drug_Cst)2022 Drug cost: $34,207 (USD; Tot_Drug_Cst)2023 Drug cost: $33,008 (USD; Tot_Drug_Cst)2024 Drug cost: $59,560 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201529283$20,839
201625341$17,472
201718157$7,929
201821353$14,181
201927282$24,944
202020222$21,432
202128160$27,555
202231254$34,207
202340323$33,008
202452451$59,560

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes3036$143

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl681,010$9,932
GabapentinGabapentin371,110$590
Quetiapine FumarateQuetiapine Fumarate24690$388
Bupropion XlBupropion Hcl13390$350
MirtazapineMirtazapine23660$312

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.18$731Gilead Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Hayman Rambaran, MD?

Tedicare shows public-source Medicare data for Hayman Rambaran, MD (NPI 1639295470), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hayman Rambaran, MD have ACO affiliation data?

Hayman Rambaran, MD is shown with ACO affiliation data for ilumed, LLC (REACH, ACO ID D0005).

What billing organization is linked to Hayman Rambaran, MD?

Hayman Rambaran, MD is linked to BERGEN COUNTY IMPROVEMENT AUTHORITY (billing NPI 1891836441) in the available physician profile data.

Does Hayman Rambaran, MD have Open Payments data?

Hayman Rambaran, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.